(ATDN) Merck Expanded Access Program

(ATDN) Merck Expanded Access Program

Treatment Review; August 1995

A new program for people with less than 50 T4 cells has been announced. Register before August 11, 1995 to be considered for Crixivan, the protease inhibitor made by a drug company called Merck. Registration is by calling 1.800.497.8383. You can call between 8 a.m. and 11p.m., 7 days a week, in English or Spanish. Due to limited supplies of the drug, if more than 1,100 people apply before that date, a lottery will be necessary to determine who gets to participate.

To participate in this program you must be at least 18 years old, and have less than 50 T4 cells. You can be taking, or already have taken 3TC, d4T, ddI, ddC or AZT, alone or in combination. You must have a platelet count greater than 50,000. You cannot have acute hepatitis, and you cannot be pregnant . You are not permitted to take any other another protease inhibitor during the study.

Other required blood values include: hemoglobin greater than 6.5; absolute neutrophil count greater than 500; creatinine less than 6 times the upper limit of normal; and blood urea nitrogen less than ten times the upper limit of normal.

You must also live in the United States and have an address where you can be reached by mail. (Someone else can register for you, and even can receive mail for you if you give your permission for them to do so.)

Anyone not selected will be placed on a waiting list in case some of the selected people decide not to take part in the study. The study may also be expanded to include those on the waiting list as more drug becomes available.

950801
ATR1902

Always watch for outdated information. This article first appeard in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1995 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1995. AEGIS.